Current Opinion in Hematology

Papers
(The TQCC of Current Opinion in Hematology is 6. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)
ArticleCitations
Novel blood derived hemostatic agents for bleeding therapy and prophylaxis62
Editorial: the new age of clinical research in clonal hematopoiesis and myeloid malignancies45
Posttransplant cyclophosphamide: a universal graft versus host disease prophylaxis44
IRAK1 and IRAK4 as emerging therapeutic targets in hematologic malignancies43
Novel immune directed therapies in myelodysplastic syndromes and acute myeloid leukemia24
Hormetic endoplasmic reticulum stress in hematopoietic stem cells24
Deficits in our understanding of natural killer cell development in mouse and human23
Heme- and iron-activated macrophages in sickle cell disease: an updated perspective23
Emerging therapeutic and preventive approaches to transplant-associated thrombotic microangiopathy19
Interferon regulatory factor-8-dependent innate immune alarm senses GATA2 deficiency to alter hematopoietic differentiation and function17
Regulation and importance of factor VIII levels in hemophilia A carriers16
Mechanisms of immunothrombosis in COVID-1916
Developmental regulation of primitive erythropoiesis16
Unraveling lipid metabolism for acute myeloid leukemia therapy15
The impact of obesity-induced inflammation on clonal hematopoiesis15
Splicing regulation in hematopoiesis15
Disparities in acute myeloid leukemia treatments and outcomes15
The new world: hematopoietic stem cell transplant during a pandemic14
Congenital neutropenia: disease models guiding new treatment strategies14
Clonal hematopoiesis and myeloid malignancies: clonal dynamics and clinical implications13
Abnormal monocyte differentiation and function in chronic myelomonocytic leukemia12
Platelet lifespan and mechanisms for clearance12
Editorial introductions11
Significance and management of isolated distal deep vein thrombosis10
Editorial introductions10
Editorial introduction10
Targeting the cluster of differentiation 47/signal-regulatory protein alpha axis in myeloid malignancies10
Editorial introductions10
Signaling mechanisms and cis-regulatory control of Samd14 in erythroid regeneration9
Thrombosis in myeloproliferative neoplasms: update in pathophysiology9
Tissue factor pathway inhibitor – cofactor-dependent regulation of the initiation of coagulation9
Editorial introductions9
Haematopoietic stem cell quiescence exposed using mitochondrial membrane potential9
Understanding and targeting erythroid progenitor cells for effective cancer therapy9
Venous thromboembolism: diagnostic advances and unaddressed challenges in management8
Red cells: not only hemoglobin – plasma membranes are also of paramount importance8
Red blood cell changes due to cancer and cancer treatments: a narrative review8
Current Opinion in Hematology8
The immunology of PF4 polyanion interactions7
Update on preclinical and clinical efforts on ex-vivo expansion of hematopoietic stem and progenitor cells7
Translation defects in ribosomopathies7
Editorial introductions7
Modeling genetic platelet disorders with human pluripotent stem cells: mega-progress but wanting more on our plate(let)7
Measurement of tissue factor-positive extracellular vesicles in plasma: strengths and weaknesses of current methods6
Modelling arterial thrombus formation in vitro6
Models to study myelodysplastic syndrome and acute myeloid leukaemia6
Chediak-Higashi syndrome6
Editorial introduction6
Challenges and opportunities in shared care for international patients treated with cellular therapy for nonmalignant disease6
A role of platelet C-type lectin-like receptor-2 and its ligand podoplanin in vascular biology6
The fulfilled promise and unmet potential of umbilical cord blood6
PROTACs in platelets: emerging antithrombotic strategies and future perspectives6
0.038270950317383